Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sight Sciences, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
SGHT
Nasdaq
3850
www.sightsciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sight Sciences, Inc.
908 Devices (MASS) Moves 19.2% Higher: Will This Strength Last?
- Jan 21st, 2026 3:41 am
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights
- Jan 13th, 2026 5:05 am
Looking At The Narrative For Sight Sciences SGHT After Medicare Coverage Shifts
- Jan 11th, 2026 10:06 pm
Sight Sciences, Inc.'s (NASDAQ:SGHT) largest shareholders are individual investors with 30% ownership, institutions own 25%
- Jan 8th, 2026 11:03 am
Here's Why You Should Add Inogen Stock to Your Portfolio Now
- Jan 2nd, 2026 6:33 am
Sight Sciences price target raised to $12 from $7 at UBS
- Dec 23rd, 2025 5:55 pm
What Makes Sight Sciences, Inc. (SGHT) a Strong Momentum Stock: Buy Now?
- Dec 18th, 2025 10:00 am
COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises
- Dec 5th, 2025 7:11 am
What Catalysts Are Changing the Story for Sight Sciences Investors?
- Nov 28th, 2025 10:13 pm
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans
- Nov 11th, 2025 5:00 am
How Recent Developments Are Changing The Sight Sciences Investment Story
- Nov 7th, 2025 10:19 pm
Sight Sciences (SGHT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
- Nov 6th, 2025 5:30 pm
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Tops Revenue Estimates
- Nov 6th, 2025 4:55 pm
Sight Sciences (SGHT) Q3 2025 Earnings Transcript
- Nov 6th, 2025 4:43 pm
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance
- Nov 6th, 2025 2:05 pm
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer
- Nov 6th, 2025 2:04 pm
Sight Sciences to Present at Two Upcoming Investor Conferences
- Nov 4th, 2025 2:05 pm
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025
- Oct 23rd, 2025 2:05 pm
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure
- Oct 17th, 2025 5:00 am
3 Promising Penny Stocks With Market Caps Up To $300M
- Oct 16th, 2025 12:05 pm
Scroll